Abildinova Gulshara Zh, Benberin Valeriy V, Vochshenkova Tamara A, Afshar Alireza, Mussin Nadiar M, Kaliyev Asset A, Zhussupova Zhanna, Tamadon Amin
Gerontology Center, Medical Center Hospital of the President's Affairs Administration of the Republic of Kazakhstan, Astana, Kazakhstan.
Corporate Foundation, Institute of Innovative and Preventive Medicine, Astana, Kazakhstan.
Front Med (Lausanne). 2024 Aug 15;11:1452227. doi: 10.3389/fmed.2024.1452227. eCollection 2024.
The human gut microbiota plays a crucial role in maintaining metabolic health, with substantial evidence linking its composition to insulin resistance. This study aims to analyze the global scholarly contributions on the relationship between intestinal microbiota and insulin resistance from 2000 to 2024.
A bibliometric analysis was conducted using data from Scopus and Web of Science Core Collection. The search strategy included terms related to "Gastrointestinal Microbiome" and "Insulin Resistance" in the title or abstract.
The analysis of 1,884 relevant studies from 510 sources was conducted, revealing a mean citation of 51.36 per manuscript and a remarkable annual growth rate of 22.08%. The findings highlight the significant role of gut microbiota in insulin resistance, corroborating prior studies that emphasize its influence on metabolic disorders. The literature review of the current study showed key mechanisms include the regulation of short-chain fatty acids (SCFAs) and gut hormones, which are critical for glucose metabolism and inflammation regulation. The analysis also identifies "Food and Function" as the most productive journal and Nieuwdorp M. as a leading author, underscoring the collaborative nature of this research area.
The consistent increase in publications in the field of gut microbiota and insulin resistance indicates growing recognition of the gut microbiota's therapeutic potential in treating insulin resistance and related metabolic disorders. Future research should focus on standardizing methodologies and conducting large-scale clinical trials to fully realize these therapeutic possibilities.
人类肠道微生物群在维持代谢健康方面发挥着关键作用,有大量证据表明其组成与胰岛素抵抗有关。本研究旨在分析2000年至2024年全球学术界对肠道微生物群与胰岛素抵抗之间关系的贡献。
使用来自Scopus和Web of Science核心合集的数据进行文献计量分析。搜索策略包括在标题或摘要中使用与“胃肠道微生物组”和“胰岛素抵抗”相关的术语。
对来自510个来源的1884项相关研究进行了分析,结果显示每篇论文的平均被引次数为51.36次,年增长率高达22.08%。研究结果突出了肠道微生物群在胰岛素抵抗中的重要作用,证实了先前强调其对代谢紊乱影响的研究。本研究的文献综述表明,关键机制包括对短链脂肪酸(SCFAs)和肠道激素的调节,这对葡萄糖代谢和炎症调节至关重要。分析还确定《食品与功能》是发文量最多的期刊,纽德波尔普·M.是主要作者,突显了该研究领域的合作性质。
肠道微生物群与胰岛素抵抗领域的出版物持续增加,表明人们越来越认识到肠道微生物群在治疗胰岛素抵抗及相关代谢紊乱方面的治疗潜力。未来的研究应侧重于规范方法并开展大规模临床试验,以充分实现这些治疗可能性。